-
NMPA to enhance cooperation with drug regulatory authorities of Vietnam, Thailand
2024-11-22
Li Li, commissioner of China's National Medical Products Administration (NMPA), led a delegation to visit Vietnam and Thailand from Nov 11 to 15 to discuss practical cooperation in drug regulation with related departments.
-
Experts stress good personal hygiene, vaccination as respiratory illnesses rise
2024-11-22
Since the risk of respiratory infectious disease has increased as temperatures drop, experts emphasized the importance of maintaining good personal hygiene and getting vaccinated promptly.
-
China, Saudi Arabia sign MoU on drug regulation
2024-11-12
Li Li, commissioner of China's National Medical Products Administration (NMPA), signed a memorandum of understanding (MoU) on cooperation with Hisham S Aljadhey, chief executive officer of the Saudi Food and Drug Authority (SFDA), on Nov 1 in Beijing, to further enhance bilateral exchanges and cooperation in drug regulation.
-
NMPA signs letter of intent on cooperation with Danish Medicines Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices in Beijing on Oct 24.
-
Li Li meets with head of Brazil’s Health Regulatory Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Antonio Barra Torres, head of Brazil's Health Regulatory Agency (Anvisa), in Beijing on Oct 21.
-
China plans credit system to curb medical insurance misuse
2024-09-29
China issued a guideline on Friday on developing a credit system for hospital and pharmacy personnel certified to process medical insurance funds in order to strengthen supervision.
